AIM ImmunoTech Inc. (AIM) Total liabilities 2016–2025
AIM ImmunoTech Inc. (AIM) total liabilities at each fiscal year-end, per SEC filings.
$15.6MFY2025 · since FY2016: $3.4M → $15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.6M | +56.7% |
| FY2024 | $9.9M | +8.6% |
| FY2023 | $9.1M | +352.8% |
| FY2022 | $2.0M | +146.3% |
| FY2021 | $820,000 | -75.1% |
| FY2020 | $3.3M | -55.0% |
| FY2019 | $7.3M | -11.5% |
| FY2018 | $8.3M | +50.2% |
| FY2017 | $5.5M | +63.1% |
| FY2016 | $3.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice